DNA/MVA Vaccines for HIV/AIDS

Since the initial proof-of-concept studies examining the ability of antigen-encoded plasmid DNA to serve as an immunogen, DNA vaccines have evolved as a clinically safe and effective platform for priming HIV-specific cellular and humoral responses in heterologous “prime-boost” vaccination regimens....

Descripción completa

Detalles Bibliográficos
Autores principales: Iyer, Smita S., Amara, Rama R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2014
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4494194/
https://www.ncbi.nlm.nih.gov/pubmed/26344473
http://dx.doi.org/10.3390/vaccines2010160

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4494194/
https://www.ncbi.nlm.nih.gov/pubmed/26344473
http://dx.doi.org/10.3390/vaccines2010160

Ejemplares similares